Nexgel Biotech Co., Ltd

Republic of Korea

Back to Profile

1-9 of 9 for Nexgel Biotech Co., Ltd Sort by
Query
Aggregations
IP Type
        Patent 7
        Trademark 2
Jurisdiction
        United States 8
        World 1
Date
2024 1
2023 1
2021 2
2020 2
Before 2020 3
IPC Class
C08G 79/025 - Polyphosphazenes 3
A61L 27/52 - Hydrogels or hydrocolloids 2
A61K 31/74 - Synthetic polymeric materials 1
A61K 31/80 - Polymers containing hetero atoms not provided for in groups 1
A61K 38/04 - Peptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof 1
See more
NICE Class
01 - Chemical and biological materials for industrial, scientific and agricultural use 2
05 - Pharmaceutical, veterinary and sanitary products 2
Status
Pending 1
Registered / In Force 8

1.

Thermosense

      
Application Number 1771151
Status Registered
Filing Date 2023-11-09
Registration Date 2023-11-09
Owner Nexgel Biotech Co., Ltd. (Republic of Korea)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Reagents for scientific or medical research use; chemicals for scientific or laboratory purposes; reagents for scientific purposes; biological tissue cultures, other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; reagents for medical research. Drug delivery agents; drug delivery agents that facilitate the delivery of pharmaceutical preparations; bone cement for surgical and orthopaedic purposes; topical gels for medical and therapeutic purposes; biological tissue cultures for medical purposes; biological preparations for medical purposes; embedding material for dental purposes; materials for tooth fillings; preparations to facilitate teething; preparations to develop teething.

2.

THERMOSENSE

      
Serial Number 79387327
Status Registered
Filing Date 2023-11-09
Registration Date 2024-12-03
Owner Nexgel Biotech Co., Ltd. (Republic of Korea)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Reagents for scientific or medical research use; chemical preparations for scientific or laboratory purposes; reagents for scientific purposes; biological tissue cultures, other than for medical or veterinary purposes; biological preparations, for use in cell cultures other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; reagents for medical research Drug delivery agents in the form of local injection, transdermal, topical, intradermal dosage, spray, implant that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; bone cement for surgical and orthopaedic purposes; topical gels for medical and therapeutic purposes, namely, local hydrogel or sprayable hydrogel improved patient compliance; biological tissue cultures for medical purposes; biological preparations for medical purposes, namely, for the treatment of wound healing, bone defect, spinal cord injury, cell therapy; embedding material in the nature of thermosensitive hydrogel containing polyphosphazene for dental purposes, namely, alveolar bone therapy; materials for tooth fillings; preparations to facilitate teething being teething prophylactics; preparations to develop teething being teething prophylactics

3.

Composition of thermosensitive hydrogels having altered reversible sol-gel transition property, and use thereof

      
Application Number 16986507
Grant Number 12168719
Status In Force
Filing Date 2020-08-06
First Publication Date 2021-06-03
Grant Date 2024-12-17
Owner Nexgel Biotech Co. Ltd (Republic of Korea)
Inventor
  • Song, Soo Chang
  • Seo, Bo-Bae

Abstract

The present invention relates to a thermosensitive hydrogel composition, which while comprising an amino acid ester, polyethylene glycol, and a functional group for the introduction of a functional moiety at an end thereof at a predetermined ratio, comprises a polyphosphazene-based polymer having a controlled length and a content of polyethylene glycol contained therein, in which a reversible sol-gel transition character is altered; a medical polymer hydrogel comprising the polyphosphazene-based polymer; or an ink composition for 3D printing.

IPC Classes  ?

  • C08G 79/025 - Polyphosphazenes
  • A61L 27/18 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
  • A61L 27/52 - Hydrogels or hydrocolloids
  • B33Y 70/10 - Composites of different types of material, e.g. mixtures of ceramics and polymers or mixtures of metals and biomaterials
  • B33Y 80/00 - Products made by additive manufacturing

4.

HYDROGEL INCLUSION COMPLEX INCLUDING PHYSIOLOGICALLY ACTIVE MATERIAL BOUND TO THERMOSENSITIVE POLY(PHOSPHAZENE) BY HOST-GUEST INTERACTION USING BETA-CYCLODEXTRIN AND USE THEREOF

      
Application Number 16906028
Status Pending
Filing Date 2020-06-19
First Publication Date 2021-01-14
Owner NEXGEL BIOTECH CO., LTD (Republic of Korea)
Inventor
  • Song, Soo Chang
  • Hong, Ki Hyun

Abstract

Provided is a hydrogel composition including thermosensitive poly(phosphazene) to which a plurality of hydrophobic amino acids, hydrophilic polymers, and host molecules are substituted; and a physiologically active material linked to a guest molecule, wherein the poly(phosphazene) and the physiologically active material form a conjugate by inclusion of the guest molecule in the host molecule via a host-guest interaction.

IPC Classes  ?

  • C08G 79/025 - Polyphosphazenes
  • C08J 3/075 - Macromolecular gels
  • C08J 3/20 - Compounding polymers with additives, e.g. colouring
  • C08J 3/24 - Crosslinking, e.g. vulcanising, of macromolecules
  • A61K 38/04 - Peptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof
  • A61K 9/50 - Microcapsules

5.

Composition for preventing or treating spinal cord injury comprising imidazole-poly(organophosphazene) hydrogel

      
Application Number 16567027
Grant Number 10799529
Status In Force
Filing Date 2019-09-11
First Publication Date 2020-03-19
Grant Date 2020-10-13
Owner NEXGEL BIOTECH CO., LTD (Republic of Korea)
Inventor
  • Song, Soo Chang
  • Kim, Young-Min

Abstract

The present disclosure relates to a pharmaceutical composition for preventing or treating spinal cord injury comprising an imidazole-poly(organophosphazene) hydrogel or a pharmaceutically acceptable salt thereof, a method for preventing or treating spinal cord injury, and a food composition for preventing or ameliorating spinal cord injury. The imidazole-poly(organophosphazene) hydrogel of the present disclosure has the effect of regenerating the extracellular matrix (ECM) by filling cystic cavities and can thus be effectively used for the prevention and treatment of spinal cord injury by a simple injection method.

IPC Classes  ?

  • A61K 31/80 - Polymers containing hetero atoms not provided for in groups
  • A61P 25/00 - Drugs for disorders of the nervous system

6.

Thermosensitive phosphazene-based polymer comprising sulfate moiety, and preparation method and use thereof

      
Application Number 16536907
Grant Number 11261271
Status In Force
Filing Date 2019-08-09
First Publication Date 2020-02-13
Grant Date 2022-03-01
Owner NEXGEL BIOTECH CO., LTD (Republic of Korea)
Inventor
  • Song, Soo Chang
  • Seo, Bo Bae

Abstract

Provided is a thermosensitive phosphazene-based polymer including an amino acid ester moiety, a polyethyleneglycol moiety, and a moiety including a sulfate group linked directly or by a linker in a predetermined ratio, a method of preparing the same, and a hydrogel-formable composition including the same. For example, a hydrogel formed from the composition may be used for tissue regeneration or drug delivery or used as a storage, a body tissue regeneration inducer, or a filler in a body.

IPC Classes  ?

  • C08F 30/02 - Homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
  • A61L 27/16 - Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/52 - Hydrogels or hydrocolloids

7.

Phosphazene-based polymer for tissue adhesion, a method for preparing the same, and use thereof

      
Application Number 15809022
Grant Number 10603404
Status In Force
Filing Date 2017-11-10
First Publication Date 2018-05-17
Grant Date 2020-03-31
Owner NEXGEL BIOTECH CO., LTD (Republic of Korea)
Inventor
  • Song, Soo Chang
  • Kim, Young-Min
  • Kim, Changho

Abstract

The present invention relates to a phosphazene-based polymer comprising an amino acid ester, polyethylene glycol, a group comprising a functional group, and a catechol group linked directly or by a linker to a part of or an entire functional group, in a predetermined ratio. In addition, the present invention relates to a preparation method thereof, and a tissue-adhesive composition comprising the same as an active ingredient.

IPC Classes  ?

  • A61L 26/00 - Chemical aspects of, or use of materials for, liquid bandages
  • A61L 24/04 - Surgical adhesives or cementsAdhesives for colostomy devices containing macromolecular materials
  • C08G 79/025 - Polyphosphazenes

8.

Poly(organophosphazene) composition for biomaterials

      
Application Number 13173783
Grant Number 08586020
Status In Force
Filing Date 2011-06-30
First Publication Date 2013-01-03
Grant Date 2013-11-19
Owner NEXGEL BIOTECH CO., LTD (Republic of Korea)
Inventor
  • Song, Soo-Chang
  • Potta, Thrimoorthy
  • Park, Mi-Ran

Abstract

Provided are a use of chemically-crosslinkable, poly(organophosphazene)s for biomaterials, chemically-crosslinkable poly(organophosphazene)s with a physiologically active substance covalently-bonded thereto, a use thereof for biomaterials, and a process for preparing the same. The chemical crosslinkings can be made by UV irradiation, and/or a crosslinker, and/or an additive, and/or an enzyme, and/or a mixing of at least one polymer.

IPC Classes  ?

  • A61K 31/74 - Synthetic polymeric materials
  • C12N 9/96 - Stabilising an enzyme by forming an adduct or a compositionForming enzyme conjugates
  • C08G 69/48 - Polymers modified by chemical after-treatment
  • C08G 63/91 - Polymers modified by chemical after-treatment
  • A61K 47/48 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

9.

Biodegradable and thermosensitive poly(organophosphazene)-superparamagnetic nanoparticle complex, preparation method and use thereof

      
Application Number 13173756
Grant Number 09017726
Status In Force
Filing Date 2011-06-30
First Publication Date 2012-05-17
Grant Date 2015-04-28
Owner NEXGEL BIOTECH CO., LTD (Republic of Korea)
Inventor
  • Song, Soo-Chang
  • Kim, Jang Il

Abstract

2* weighted image, and the poly(organophosphazene) shows a sol-to-gel behavior depending upon the temperature change. The complex is a bound-type where the superparamagnetic ferrite nanoparticle is bonded to phosphazene-based polymer via hydrophobic binding, and a mixed-type where the superparamagnetic ferrite nanoparticle is physically mixed with the phosphazene-based polymer.

IPC Classes  ?

  • A61K 9/14 - Particulate form, e.g. powders
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 49/18 - Nuclear magnetic resonance [NMR] contrast preparationsMagnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
  • B82Y 15/00 - Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
  • C08G 79/02 - Macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon a linkage containing phosphorus
  • C08L 85/02 - Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbonCompositions of derivatives of such polymers containing phosphorus